(Z)-10-((Z)-dec-4-en-1-yl)-2,6-dimethylicos-14-en-9-yl 5-bromopentanoate | 1450889-59-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (Z)-10-((Z)-dec-4-en-1-yl)-2,6-dimethylicos-14-en-9-yl 5-bromopentanoate
• 英文别名: [(Z)-10-[(Z)-dec-4-enyl]-2,6-dimethylicos-14-en-9-yl] 5-bromopentanoate
• CAS: 1450889-59-4
• 化学式: C₃₇H₆₉BrO₂
• 分子量: 625.858
• InChiKey: GGCNQUCNGHHUFF-RYOQUFEFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  14.9
• 重原子数：
  40
• 可旋转键数：
  30
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• [EN] TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF<br/>[FR] LIPIDES CATIONIQUES TRIALKYLÉS ET LEURS PROCÉDÉS D'UTILISATION
  申请人：PROTIVA BIOTHERAPEUTICS INC

  公开号：WO2013126803A1

  公开（公告）日：2013-08-29

  The present invention provides compositions and methods for the delivery of therapeutic agents to cells. In particular, these include novel, trialkyl, cationic lipids and nucleic acid-lipid particles that provide efficient encapsulation of nucleic acids and efficient delivery of the encapsulated nucleic acid to cells in vivo. The compositions of the present invention are highly potent, thereby allowing effective knock-down of a specific target protein at relatively low doses.

  本发明提供了用于将治疗剂传递给细胞的组合物和方法。具体包括新颖的三烷基阳离子脂质和核酸-脂质颗粒，这些颗粒能够有效地封装核酸并将封装的核酸有效地传递给体内的细胞。本发明的组合物非常有效，因此可以在相对较低的剂量下有效地降低特定靶蛋白的表达。
• TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF
  申请人：PROTIVA BIOTHERAPEUTICS, INC.

  公开号：US20150064242A1

  公开（公告）日：2015-03-05

  The present invention provides compositions and methods for the delivery of therapeutic agents to cells. In particular, these include novel, trialkyl, cationic lipids and nucleic acid-lipid particles that provide efficient encapsulation of nucleic acids and efficient delivery of the encapsulated nucleic acid to cells in vivo. The compositions of the present invention are highly potent, thereby allowing effective knock-down of a specific target protein at relatively low doses.

  本发明提供了用于向细胞传递治疗剂的组合物和方法。特别地，这些包括新型的三烷基阳离子脂质和核酸-脂质颗粒，这些颗粒提供了核酸的高效封装和在体内有效地传递该封装的核酸到细胞的方法。本发明的组合物非常有效，因此在相对较低的剂量下允许有效地抑制特定靶蛋白。
• Trialkyl cationic lipids and methods of use thereof
  申请人：ARBUTUS BIOPHARMA CORPORATION

  公开号：US10561732B2

  公开（公告）日：2020-02-18

  The present invention provides compositions and methods for the delivery of therapeutic agents to cells. In particular, these include novel, trialkyl, cationic lipids and nucleic acid-lipid particles that provide efficient encapsulation of nucleic acids and efficient delivery of the encapsulated nucleic acid to cells in vivo. The compositions of the present invention are highly potent, thereby allowing effective knock-down of a specific target protein at relatively low doses.

  本发明提供了向细胞输送治疗剂的组合物和方法。其中特别包括新型的三烷基阳离子脂质和核酸-脂质颗粒，它们能有效地封装核酸并将封装的核酸高效地输送到体内细胞。本发明的组合物具有很高的效力，因此能以相对较低的剂量有效地敲除特定的靶蛋白。
• US9352042B2
  申请人：——

  公开号：US9352042B2

  公开（公告）日：2016-05-31